US Patent 8410250 Anti-FGFR3 antibodies and methods using same
Patent 8410250 was granted and assigned to Genentech on April, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+122 characters)
Article
Patent abstract
The invention provides FGFR3 antibodies, and compositions comprising and methods of using these antibodies.
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Avi Ashkenazi0
Christian Wiesmann0
Jing Qing0
Yan Wu0
Edits on 19 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 12 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08410250 Anti-FGFR3 antibodies and methods using same US Patent 8410250 Anti-FGFR3 antibodies and methods using same
Infobox
Patent Number
084102500
Patent Number
84102500
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
084102500
Date of Patent
April 2, 2013
0Patent Application Number
127311000
Date Filed
March 24, 2010
0Patent Primary Examiner
Edits on 16 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08410250 Anti-FGFR3 antibodies and methods using same
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08410250
Date of patent
April 2, 2013
Patent application number
12731100
Date Filed
March 24, 2010
Patent primary examiner
Find more entities like US Patent 8410250 Anti-FGFR3 antibodies and methods using same
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.